These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 7056165)
1. [Preparation and testing of a hepatitis B vaccine (author's transl)]. Thomssen R; Gerlich W; Böttcher U; Stibbe W; Legler K; Weinmann E; Klinge O; Pfeifer U Dtsch Med Wochenschr; 1982 Jan; 107(4):125-31. PubMed ID: 7056165 [TBL] [Abstract][Full Text] [Related]
2. Safety and potency aspects in the preparation of an experimental HBsAg vaccine. Thomssen R; Gerlich WH; Böttcher U; Legler K; Ritter S; Stibbe W; Weinmann W; Klinge O; Pfeifer U Dev Biol Stand; 1983; 54():23-31. PubMed ID: 6228464 [TBL] [Abstract][Full Text] [Related]
3. Clinical trial of hepatitis B vaccine in a simplified immunization programme. Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032 [TBL] [Abstract][Full Text] [Related]
4. Viral hepatitis type B: propects for active immunization. Krugman S Dev Biol Stand; 1975; 30():363-7. PubMed ID: 1204971 [TBL] [Abstract][Full Text] [Related]
5. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients. Scheiermann N; Kuwert EK Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers. Das HS; Sawant P; Shirhatti RG; Vyas K; Vispute S; Dhadphale S; Patrawalla V; Desai N Trop Gastroenterol; 2002; 23(3):120-1. PubMed ID: 12693152 [TBL] [Abstract][Full Text] [Related]
7. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine. Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875 [TBL] [Abstract][Full Text] [Related]
8. [Active immunization against hepatitis B]. Wildgrube HJ; Classen M; von Lohr R; Kurth R; Brede HD Dtsch Med Wochenschr; 1984 Feb; 109(7):246-50. PubMed ID: 6230216 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982). Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468 [TBL] [Abstract][Full Text] [Related]
10. [Experiments for the development of a hepatitis B vaccine: immunogenicity of HBsAg in guinea pigs (author's transl)]. Stamm B; Gerlich W; Thomssen R Med Microbiol Immunol; 1979 May; 167(2):83-97. PubMed ID: 572908 [TBL] [Abstract][Full Text] [Related]
11. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal). Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150 [TBL] [Abstract][Full Text] [Related]
12. A new hepatitis B vaccine containing HBeAg in addition to HBsAg. Prince AM; Vnek J; Stephan W Dev Biol Stand; 1983; 54():13-22. PubMed ID: 6228452 [TBL] [Abstract][Full Text] [Related]
13. Low dose hepatitis B vaccination in children. Milne A; Allwood GK; Pearce NE; Lucas CR; Krugman S N Z Med J; 1986 Feb; 99(795):47-9. PubMed ID: 2935755 [TBL] [Abstract][Full Text] [Related]
14. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen. Frazer IH; Jones B; Dimitrakakis M; Mackay IR Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303 [TBL] [Abstract][Full Text] [Related]
15. [Vaccination against hepatitis B in man]. Maupas P; Goudeau A; Coursaget P; Drucker J; Bagros P; Baudin S Nouv Presse Med; 1977 Jan; 6(1):27-31. PubMed ID: 401985 [TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161 [TBL] [Abstract][Full Text] [Related]
17. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years. Kurugöl Z; Mutlubaş F; Ozacar T Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736 [TBL] [Abstract][Full Text] [Related]
18. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults. Just M; Berger R; Just V Postgrad Med J; 1987; 63 Suppl 2():121-3. PubMed ID: 3317346 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study. Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis B in haemodialysis: vaccination against HBS antigen. Crosnier J Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]